LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 2012 | 10605 | 0.1897 | 0.1089 |
MCF 10A | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 3910 | 10605 | 0.3687 | 0.3057 |
MCF 10A | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 962 | 10851 | 10605 | 1.0232 | 1.0255 |
MCF 10A | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 2213 | 10605 | 0.2087 | 0.1298 |
MCF 10A | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 8386 | 10605 | 0.7908 | 0.7699 |
MCF 10A | R406 | 0.37 | uM | LJP6 | 72 | hr | 962 | 9328 | 10605 | 0.8796 | 0.8676 |
MCF 10A | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 962 | 7038 | 10605 | 0.6637 | 0.6302 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 2267 | 10605 | 0.2138 | 0.1354 |
MCF 10A | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 962 | 840 | 10605 | 0.0793 | -0.0126 |
MCF 10A | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 962 | 706 | 10605 | 0.0666 | -0.0265 |
MCF 10A | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 962 | 5546 | 10605 | 0.5230 | 0.4754 |
MCF 10A | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 962 | 7429 | 10605 | 0.7005 | 0.6706 |
MCF 10A | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 962 | 8562 | 10605 | 0.8074 | 0.7882 |
MCF 10A | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 962 | 899 | 10605 | 0.0848 | -0.0066 |
MCF 10A | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 962 | 8775 | 10605 | 0.8274 | 0.8102 |
MCF 10A | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 962 | 2477 | 10605 | 0.2336 | 0.1571 |
MCF 10A | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 962 | 8630 | 10605 | 0.8138 | 0.7952 |
MCF 10A | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 962 | 8600 | 10605 | 0.8110 | 0.7921 |
MCF 10A | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 10628 | 10605 | 1.0022 | 1.0024 |
MCF 10A | JNK-9L | 0.37 | uM | LJP6 | 72 | hr | 962 | 5911 | 10605 | 0.5574 | 0.5132 |
MCF 10A | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 962 | 9787 | 10605 | 0.9229 | 0.9152 |
MCF 10A | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 10615 | 10605 | 1.0010 | 1.0011 |
MCF 10A | LDN-193189 | 0.37 | uM | LJP5 | 72 | hr | 962 | 9892 | 10605 | 0.9328 | 0.9261 |
MCF 10A | Linifanib | 0.37 | uM | LJP6 | 72 | hr | 962 | 11407 | 10605 | 1.0756 | 1.0832 |
MCF 10A | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 9986 | 10605 | 0.9416 | 0.9358 |